Clinical Trial: Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPV

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762209) titled 'Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPV' on Aug. 04.

Brief Summary: This randomized, open-label, multicenter clinical study is designed to evaluate Papilozumib(R) vaginal gel in women aged 30 to 50 years who test positive for human papillomavirus (HPV) and present with either normal cervical cytology or cytological findings of atypical squamous cells of undetermined significance (ASC-US), low-grade squamous intraepithelial lesion (LSIL), or atypical glandular cells (AGC), accompanied by corresponding colposcopic findings.

Eighty-one participants will be randomly assigned in equal groups to rece...